The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis.
Jonathan BrettAndrea L SchafferTimothy DobbinsNicholas A BuckleySallie-Anne PearsonPublished in: Pharmacoepidemiology and drug safety (2018)
More nuanced policies are needed to ensure the appropriate access to 25-mg quetiapine for dose escalation while discouraging use for indications where the evidence of risk and benefit is unclear.